FDA to Evaluate Minimally or Non-Addictive Cigarette Product Standard, Also Plans to Look at Flavors and Premium Cigars

by Saul Ewing Arnstein & Lehr LLP

Earlier today, U.S. Food and Drug Administration (FDA or the Agency) Commissioner Scott Gottlieb, M.D., announced FDA’s issuance of an advance notice of proposed rulemaking (ANPRM) to explore a product standard to lower nicotine in cigarettes to minimally or non-addictive levels (Nicotine ANPRM).  Gottlieb’s announcement comes nearly eight months after the Agency unveiled its planned tobacco regulatory policy shift to place nicotine, and the issue of addiction, at the center of FDA’s tobacco regulatory efforts, which we discussed here.

In addition to offering some of the details of the Nicotine ANPRM, Gottlieb also indicated today that FDA will soon issue two additional ANPRMs: one to seek comment on the role that flavors – including menthol – play in initiation, use, and cessation of tobacco products (Flavor ANPRM), and a second to solicit additional comments and data related to the regulation of premium cigars (Premium Cigar ANPRM).  As reported by Inside Health Policy on March 7, 2018, the White House Office of Management and Budget (OMB) has already cleared the Menthol ANPRM and the Premium Cigar ANPRM.

The Nicotine ANPRM, which will be published in the March 16, 2018 edition of the Federal Register, provides a wide-ranging review of the current scientific understanding about the role nicotine plays in creating or sustaining addiction to cigarettes and seeks comment from the public as well as additional research and data for public review for FDA to consider as it evaluates a nicotine product standard.  More specifically, FDA is asking for feedback on a number of questions, including:

  • What potential maximum nicotine level would be appropriate for the protection of public health?
  • Should a product standard be implemented all at once or gradually?
  • What unintended consequences - such as the potential for illicit trade or for addicted smokers to compensate for lower nicotine by smoking more - might occur as a result?
  • How should potential consumer surplus or utility loss from the removal of nicotine in cigarettes be considered, given the availability of other sources of nicotine such as electronic nicotine delivery systems (ENDS) (e.g., c-cigarettes and vapor products) and the continued availability of combustible tobacco products?

On the topic of ENDS, the Agency refers to such products in the Nicotine ANPRM as “potentially less hazardous” than other tobacco products (i.e., combustible tobacco products).  This is a continuation of a theme introduced for the first time in FDA’s announcement in July 2017 that within the continuum of risk of tobacco products, nicotine is most harmful when delivered through smoke particles in combustible cigarettes.

With regard to the soon-to-be released Flavor ANPRM, as some may know, there is already a flavored combustible cigarette ban in place, as established by in the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act).  However, Congress specifically carved menthol out of that ban, and mentholated cigarettes continue to be available.  In addition, the flavor ban does not apply to non-combustible products (i.e., ENDS products), and flavored vapor products are wildly popular.  This begs the question: what exactly will the Flavor ANPRM contain?  Recall the language used by Commissioner Gottlieb in today’s announcement: FDA plans to seek comment on “the role that flavors – including menthol – play in initiation, use and cessation of tobacco products.”  If FDA moves to restrict menthol, it would not be the first time the Agency has tried to regulate the flavor.  By way of background, in July 2013, FDA issued an ANPRM to obtain public input on menthol in cigarettes but the Agency never moved forward with regulatory action on the same, due in large part to a successful industry challenge to the menthol report issued by FDA’s Tobacco Products Scientific Advisory Committee (TPSAC).  While the U.S. Court of Appeals for the D.C. Circuit eventually upheld the Agency’s right to rely on TPSAC’s menthol report, FDA did not pursue further regulatory action.  In addition to or in lieu of menthol, the ANPRM will likely address ENDS product flavors.  Per the pre-rule abstract on OMB, Office of Information and Regulatory Affairs’ (OIRA) website, the “Kid-Appealing Flavors in Tobacco Products…ANPRM will seek information on how [FDA] might regulate flavors in tobacco products to limit appeal to youth while taking into account the potential role that some flavors may play in helping some users transition away from combusted products.”  This excerpt sums up nicely the current debate about flavored ENDS products: how does the Agency limit appeal to youth while preserving adult choice and helping adults transition away from combustible products, which FDA suggests could be more harmful than ENDS products?

On the topic of premium cigars, Commissioner Gottlieb indicated in a speech last July that FDA is considering whether and how the Agency would exempt such cigars from the Deeming Rule, and that FDA plans to ask for “new information related to the patterns of use and resulting public health impacts from so-called premium cigars.”  While the Agency’s Deeming Rule covers all cigars, Gottlieb has said that FDA will “explore any new and different questions raised, and seriously consider any additional data submitted relevant to the appropriate regulatory status of premium cigars.”  It is expected that the Agency will ask for this and other feedback in its Premium Cigar ANPRM.

To be sure, FDA is still a long way off from promulgating nicotine, flavor, and/or premium cigar regulations.  Between now and issuing final rules, the Agency would have to, among other things: (1) consider public comments received on the ANPRMs; (2) issue proposed regulations; (3) consider public comments received on the proposed rules; and (4) issue final regulations.  Moreover, the dates by which industry would need to comply with final regulations, if any, would probably not be immediate, as effective and compliance dates would likely be staggered.  And of course the Agency could give small-scale tobacco product manufacturers even more time to comply with final rules, as is FDA’s custom.  With that said, it is possible that the Agency will merely publish the above-referenced ANPRMs and then take no further action.  As discussed above, there is some precedent for this in the tobacco regulatory space.  On the other hand, Commissioner Gottlieb has addressed repeatedly the importance of these dockets, including in his December 2017 blog post on FDA’s major policy goals for 2018 and in a January 2018 speech to Agency staff regarding the same.

Beyond announcing the issuance of the Nicotine ANPRM and indicating that release of the Flavor and Premium Cigar ANPRMs is imminent, Commissioner Gottlieb also discussed that the Agency is continuing to re-evaluate and modernize its approach to the development and regulation of safe and effective medicinal nicotine replacement products such as nicotine gums, patches, and lozenges that help smokers quit.  Gottlieb, together with Janet Woodcock, M.D., Director of FDA’s Center for Drug Evaluation and Research (CDER), and Mitch Zeller, J.D., Director of FDA’s Center for Tobacco Products (CTP), issued a blog post on this topic in November 2017.  

Finally, Gottlieb also addressed in the announcement that the Agency plans to take new steps to ensure that its policies and processes for the regulation of tobacco products are efficient and predictable, and consistent with the mandate Congress gave FDA under the Tobacco Control Act.  More specifically, he indicated that the Agency plans to issue a series of foundational rules and guidance documents on regulatory process, including on the demonstration of substantial equivalence (SE) and the submission of applications for new tobacco products, and release soon a framework for how FDA will address provisional SEs.  

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Saul Ewing Arnstein & Lehr LLP | Attorney Advertising

Written by:

Saul Ewing Arnstein & Lehr LLP

Saul Ewing Arnstein & Lehr LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.